Multiple Myeloma
Showing NaN - NaN of 82
Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
-
Orange, California
- +270 more
Apr 11, 2023
Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)
Recruiting
- Multiple Myeloma
-
Anchorage, Alaska
- +698 more
Jan 24, 2023
Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)
Completed
- Multiple Myeloma
-
Birmingham, Alabama
- +60 more
Jan 24, 2023
Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Daratumumab IV
- +3 more
-
Birmingham, Alabama
- +211 more
Jan 17, 2023
Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Ixazomib
- +2 more
-
Duarte, California
- +9 more
Jan 11, 2023
Multiple Myeloma Trial in Worldwide (Modakafusp alfa, Lenalidomide, Bortezomib)
Recruiting
- Multiple Myeloma
- Modakafusp alfa
- +5 more
-
Little Rock, Arkansas
- +53 more
Jan 12, 2023
Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib 20 mg/m^2
- +4 more
-
Gilbert, Arizona
- +107 more
Dec 20, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
Multiple Myeloma Trial in Japan, United States (JNJ-68284528)
Completed
- Multiple Myeloma
- JNJ-68284528
-
Phoenix, Arizona
- +20 more
Oct 5, 2022
Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))
Recruiting
- Multiple Myeloma
- Cilta-cel
- Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
-
Duarte, California
- +23 more
Aug 1, 2022
Multiple Myeloma Trial in United States (Magrolimab, Daratumumab, Pomalidomide)
Recruiting
- Multiple Myeloma
- Magrolimab
- +5 more
-
Tucson, Arizona
- +8 more
Jul 28, 2022